Search research articles
Contact Us
Filters
Showing results (251-260 of 791) with videos related to
Page
of 80
Sort By:
Leukemia & Lymphoma
|
April 12, 2013
Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation
Fabio P S Santos, Constantine S Tam, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 29, 2017
Sepsis and Acute Myeloid Leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals
Imrana A Malik, Marylou Cardenas-Turanzas, Susan Gaeta, et al.
Leukemia Research
|
February 18, 2015
Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities
Christopher B Benton, Maria Tanaka, Catherine Wilson, et al.
Cancer
|
June 16, 2004
Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia
Alfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, et al.
Cancer
|
May 26, 2004
Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase
Jorge Cortes, Susan O'Brien, Alfonso Quintas, et al.
Cancer Chemotherapy and Pharmacology
|
December 24, 2002
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia
Yesid Alvarado, Jorge Cortes, Srdan Verstovsek, et al.
Haematologica
|
September 14, 2014
Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib
Adam Olshen, Min Tang, Jorge Cortes, et al.
Leukemia & Lymphoma
|
January 5, 2016
CD33 is frequently expressed in cases of myelodysplastic syndrome and chronic myelomonocytic leukemia with elevated blast count
David Sanford, Guillermo Garcia-Manero, Jeffrey Jorgensen, et al.
Cancer Science
|
June 19, 2010
Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays
C Cameron Yin, Jorge Cortes, John Galbincea, et al.
Leukemia Research
|
September 29, 2007
Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy
Iman Jilani, Hagop Kantarjian, Mercedes Gorre, et al.
Page
of 80
Search research articles
Search
Showing results (251-260 of 791) with videos related to
Sort By:
Page
of 80
Leukemia & Lymphoma
|
April 12, 2013
Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation
Fabio P S Santos, Constantine S Tam, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 29, 2017
Sepsis and Acute Myeloid Leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals
Imrana A Malik, Marylou Cardenas-Turanzas, Susan Gaeta, et al.
Leukemia Research
|
February 18, 2015
Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities
Christopher B Benton, Maria Tanaka, Catherine Wilson, et al.
Cancer
|
June 16, 2004
Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia
Alfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, et al.
Cancer
|
May 26, 2004
Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase
Jorge Cortes, Susan O'Brien, Alfonso Quintas, et al.
Cancer Chemotherapy and Pharmacology
|
December 24, 2002
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia
Yesid Alvarado, Jorge Cortes, Srdan Verstovsek, et al.
Haematologica
|
September 14, 2014
Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib
Adam Olshen, Min Tang, Jorge Cortes, et al.
Leukemia & Lymphoma
|
January 5, 2016
CD33 is frequently expressed in cases of myelodysplastic syndrome and chronic myelomonocytic leukemia with elevated blast count
David Sanford, Guillermo Garcia-Manero, Jeffrey Jorgensen, et al.
Cancer Science
|
June 19, 2010
Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays
C Cameron Yin, Jorge Cortes, John Galbincea, et al.
Leukemia Research
|
September 29, 2007
Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy
Iman Jilani, Hagop Kantarjian, Mercedes Gorre, et al.
Page
of 80